WEBSITE BSE:543546 NSE : HEALTHYLIFE 18 May, 12:50
Market Cap ₹29 Cr.
Stock P/E
P/B 1.2
Current Price ₹13.1
Book Value ₹ 11.1
Face Value 10
52W High ₹13.1
Dividend Yield 0%
52W Low ₹ 3.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|
| Net Sales | 34 | 108 | |
| Other Income | 0 | 0 | |
| Total Income | 34 | 108 | |
| Total Expenditure | 33 | 106 | |
| Operating Profit | 1 | 2 | |
| Interest | 0 | 0 | |
| Depreciation | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | |
| Profit Before Tax | 1 | 2 | |
| Provision for Tax | 0 | 1 | |
| Profit After Tax | 1 | 2 | |
| Adjustments | -0 | -0 | |
| Profit After Adjustments | 1 | 2 | |
| Adjusted Earnings Per Share | 0.8 | 0.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 218% | 0% | 0% | 0% |
| Operating Profit CAGR | 100% | 0% | 0% | 0% |
| PAT CAGR | 100% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 123% | NA% | NA% | NA% |
| ROE Average | 9% | 8% | 8% | 8% |
| ROCE Average | 12% | 11% | 11% | 11% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 |
|---|---|---|
| Shareholder's Funds | 11 | 24 |
| Minority's Interest | 0 | 0 |
| Borrowings | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 |
| Total Current Liabilities | 4 | 2 |
| Total Liabilities | 15 | 27 |
| Fixed Assets | 2 | 2 |
| Other Non-Current Assets | 0 | 0 |
| Total Current Assets | 13 | 25 |
| Total Assets | 15 | 27 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 |
| Cash Flow from Operating Activities | -8 | -12 |
| Cash Flow from Investing Activities | -2 | -1 |
| Cash Flow from Financing Activities | 11 | 12 |
| Net Cash Inflow / Outflow | 1 | -1 |
| Closing Cash & Cash Equivalent | 1 | 0 |
| # | Mar 2022 | Mar 2023 |
|---|---|---|
| Earnings Per Share (Rs) | 0.81 | 0.69 |
| CEPS(Rs) | 0.87 | 0.75 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 10.88 | 11.09 |
| Core EBITDA Margin(%) | 3.5 | 2.15 |
| EBIT Margin(%) | 3.37 | 2.03 |
| Pre Tax Margin(%) | 3.3 | 1.92 |
| PAT Margin (%) | 2.44 | 1.4 |
| Cash Profit Margin (%) | 2.56 | 1.52 |
| ROA(%) | 5.59 | 7.18 |
| ROE(%) | 7.61 | 8.56 |
| ROCE(%) | 9.76 | 11.7 |
| Receivable days | 29.57 | 20.37 |
| Inventory Days | 6.62 | 5.22 |
| Payable days | 14.14 | 2.79 |
| PER(x) | 0 | 9 |
| Price/Book(x) | 0 | 0.56 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 0.29 | 0.13 |
| EV/Core EBITDA(x) | 8.17 | 6.24 |
| Net Sales Growth(%) | 0 | 217.49 |
| EBIT Growth(%) | 0 | 91.02 |
| PAT Growth(%) | 0 | 82.42 |
| EPS Growth(%) | 0 | -15.65 |
| Debt/Equity(x) | 0.08 | 0.05 |
| Current Ratio(x) | 3.39 | 10.05 |
| Quick Ratio(x) | 3.24 | 9.06 |
| Interest Cover(x) | 44.05 | 19.16 |
| Total Debt/Mcap(x) | 0 | 0.09 |
| # | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 54.57 | 54.57 | 27.31 | 27.31 |
| FII | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 |
| Public | 45.43 | 45.43 | 72.69 | 72.69 |
| Others | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 |
| # | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 1.2 | 1.2 | 0.6 | 0.6 |
| FII | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 |
| Public | 1 | 1 | 1.6 | 1.6 |
| Others | 0 | 0 | 0 | 0 |
| Total | 2.2 | 2.2 | 2.2 | 2.2 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
